# Shortened Regimen for Drug-susceptible TB in Children

> **NCT06253715** · PHASE3 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 860 (estimated)

## Conditions studied

- Tuberculosis
- Tuberculosis, Pulmonary
- Tuberculosis, Lymph Node
- Mycobacterium Tuberculosis

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** Rifampin
- **DRUG:** Pyrazinamide
- **DRUG:** Ethambutol
- **DRUG:** Rifapentine
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT06253715
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 860 (ESTIMATED)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06253715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06253715, "Shortened Regimen for Drug-susceptible TB in Children". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06253715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*